SIRPA and Alzheimer disease: It has been found that CD47–SIRPα signaling could protect synapse from excess microglia-mediated phagocytosis in developing retinogeniculate system (Lehrman et al., 2018), as well as in model of Alzheimer’s disease (Ding et al., 2021).